Tell us about the challenges you navigate when treating patients with DLBCL in your practice

What are the primary challenges you face in diagnosing diffuse large B-cell lymphoma (DLBCL)?
Limited access to diagnostic tools
Delayed referral from primary care
Ambiguous clinical presentations
Lack of experience with DLBCL-specific symptoms
How challenging is it to stay updated with the latest treatment guidelines for DLBCL?
Very challenging
Somewhat challenging
Not very challenging
Not challenging at all
Which of the following is the most significant barrier to administering optimal treatment for DLBCL?
Patient comorbidities
Drug access and availability
Insurance coverage and cost issues
Limited time for patient education
What is the most common issue you encounter when managing treatment-related side effects in DLBCL patients?
Lack of supportive care resources
Difficulty in managing severe side effects
Patient adherence to treatment plans
Inadequate follow-up care
What is your biggest challenge in patient communication and education regarding DLBCL?
Explaining complex treatment options
Addressing patient and family anxiety
Managing patient expectations
Ensuring patient understanding of treatment risks and benefits
When educating patients who are receiving first- or second-line therapies do you mention potential later-line therapies, or do you wait until the patient's disease has progressed?
I provide a potential roadmap for future therapies when initiating first-line therapy
I will mention later-line therapies once disease has progressed past first line
I try to focus on each line of therapy as it happens
I will discuss later-line therapies while in the first line if the patients asks for information
Which aspect of patient management do you find most difficult to address in DLBCL patients?
Psychosocial support
Treatment adherence
Managing relapses or treatment failure
End-of-life care discussions
What is the most significant challenge you face in coordinating care for DLBCL patients across different healthcare settings?
Communication between care teams
Coordination of treatment schedules
Variability in care quality across settings
Ensuring consistent patient follow-up
{"name":"Tell us about the challenges you navigate when treating patients with DLBCL in your practice", "url":"https://www.poll-maker.com/QMM559EGT","txt":"What are the primary challenges you face in diagnosing diffuse large B-cell lymphoma (DLBCL)?, How challenging is it to stay updated with the latest treatment guidelines for DLBCL?, Which of the following is the most significant barrier to administering optimal treatment for DLBCL?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}